ResearcherHangzhou City UniversityActive in the last 2 years

Mengjie Gu

Verified by OpenAlex author ID (good confidence)As of 13 November 2026

Matched on OpenAlex author ID A5150821589.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 1 (first author 1, last author 0)
Pancreatic cancer trials: 0
Pancreatic cancer grants: 0
Collaborators: 1

Papers, trials and grants by year

2026: 1 paper

Papers 1

Vortioxetine enhances the anti-pancreatic cancer efficacy of gemcitabine through reducing MAOB expression. First author DOI 10.3389/fphar.2026.1856439 ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Zejun Wang · 1 shared paper, 2026
- Paper Vortioxetine enhances the anti-pancreatic cancer efficacy of gemcitabine through reducing MAOB expression. DOI 10.3389/fphar.2026.1856439 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.